MedPath
FDA Approval

Neo Polycin HC

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Padagis US LLC
DUNS: 967694121
Effective Date
December 10, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Neomycin(3.5 mg in 1 g)
Polymyxin B(10000 [USP'U] in 1 g)
Bacitracin(400 [USP'U] in 1 g)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neo Polycin HC

Product Details

NDC Product Code
0574-4144
Application Number
ANDA062166
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
November 9, 2018
NeomycinActive
Code: 057Y626693Class: ACTIMQuantity: 3.5 mg in 1 g
Code: 19371312D4Class: ACTIMQuantity: 10000 [USP'U] in 1 g
Code: 89Y4M234ESClass: ACTIMQuantity: 400 [USP'U] in 1 g
PETROLATUMInactive
Code: 4T6H12BN9UClass: IACT
Code: 3X7931PO74Class: ACTIBQuantity: 10 mg in 1 g
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath